Neogen Chemicals Limited has informed the Exchange regarding 'Disclosure under regulation 7(2) of SEBI PIT regulations'.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 1.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Haridas Thakarshi Kanani, Promoter and Chairman Emeritus of Neogen Chemicals, transferred 57,78,500 equity shares (21.90% of paid-up capital) to two family trusts — Haridas Kanani Family Trust (52,76,500 shares, ~20%) and H T Kanani Family Trust (5,02,000 shares, ~1.90%) — via an off-market gift transaction on December 31, 2025. SEBI had granted an exemption order (dated December 30, 2025) allowing the trusts to be classified as Promoter/Promoter Group shareholders post-acquisition. As a result, Kanani's direct personal holding dropped sharply from 61,53,887 shares (23.33%) to just 3,75,387 shares (1.42%). The reference market price was Rs. 1,163.20 per share based on NSE closing on December 30, 2025.
This is a restructuring of promoter holdings via family trusts rather than a market sale, so there is no cash outflow or change in ultimate promoter control. Short-term, the stock is unlikely to see pressure since no shares hit the open market; long-term, the move consolidates the Kanani family's stake within trust structures, which could affect how future dividends and voting rights are exercised.